.

ARTIFICIAL INTELLIGENCE IN
ENHANCING MEDICATION
SAFETY
AND ACCURACY IN
COMPOUNDING

INTRODUCTION
Artificial intelligence (AI) stands as one of computer science's most established disciplines,
encompassing a wide range of topics. Its scope extends to replicating human-like cognitive abilities to
address real-world challenges. The field also focuses on developing systems capable of learning and
reasoning in ways that resemble human thought processes. The recent surge in attention toward
artificial intelligence can be attributed largely to the remarkable practical achievements in the field of
machine learning (ML). These tangible successes have sparked widespread curiosity and enthusiasm
across various sectors. The application of artificial intelligence (AI) in healthcare has become a focal
point for both scientific researchers and medical practitioners. However, there's been limited
exploration of this subject from a cross-disciplinary viewpoint. Such a comprehensive approach would
incorporate insights from diverse fields, including accounting, business administration, management
studies, decision-making sciences, and various health-related professions.

The study also examines how the COVID-19 crisis has sped up the adoption of AI in healthcare,
particularly in areas like remote medical services and automated communication systems, which have
improved access to care and enhanced medical training. The paper then looks ahead, considering AI's
potential to transform healthcare while also critically evaluating the ethical and social challenges that
come with integrating these advanced technologies. It explores how AI might help reduce inequalities
in healthcare access and outcomes , while also addressing the ethical concerns related to data use and
patient confidentiality. The authors stress the importance of developing and updating guidelines to
oversee the responsible use of AI in the medical field.

In recent years, artificial intelligence (AI) has proven itself to be an increasingly valuable and
dependable technology across multiple domains, with a notable impact in the field of healthcare. AI
offers potential benefits for patients, such as making healthcare more accessible, which could result in
higher satisfaction rates and better adherence to treatment plans. However, AI, like any new
technology, comes with its own set of constraints and possible drawbacks. These issues need to be
carefully identified and resolved before the healthcare sector can confidently expand its use of AI
technologies. Artificial intelligence has reached a stage where it can assist healthcare workers across a
wide range of activities. These include streamlining administrative processes, improving clinical
record-keeping, and enhancing patient communication. Additionally, AI is capable of providing
specialized assistance in areas such as analyzing medical images, automating medical equipment, and
continuously monitoring patients' conditions.

The healthcare ecosystem is realizing the importance of AI-powered tools in the next-generation
healthcare technology. It is believed that AI can bring improvements to any process within healthcare
operation and delivery. For instance, the cost savings that AI can bring to the healthcare system is an
important driver for implementation of AI applications. AI technology enables rapid and simultaneous
analysis of diverse medical test results, potentially reducing costs, saving time, and streamlining
patient care. Currently, AI tools are employed in treatment planning and medication decisions by
interpreting various imaging studies such as X-rays, CT scans, and MRIs, along with other clinical data.
The COVID-19 pandemic triggered a significant surge in demand for AI-powered healthcare solutions,
leading to the development of numerous new technologies during this period.

1567 1820
1976 2011
2 021
1382

AI

AI: TIMELINE AND LEGACY

The concept of artificial intelligence has been pondered for centuries, with ancient philosophers
contemplating the nature of life and death. Mechanical devices known as automatons, which operated
independently of human control, were invented in ancient times. Derived from the ancient Greek
word "automaton," meaning "acting of one's own will," these early automatons showcased the
ingenuity of their creators. One of the earliest recorded examples is a mechanical pigeon attributed to
a friend of Plato, dating back to 400 BCE. Centuries later, Leonardo da Vinci gained acclaim for his
creation of a remarkable automaton around the year 1495.

1943: The groundwork for modern artificial intelligence was laid in 1943 by Warren McCulloch and
Walter Pitts, who introduced a model of artificial neurons. Their pioneering work marked a significant
milestone in the development of AI.

1949: Donald Hebb's 1949 research introduced a method for adjusting the strength of connections
between neurons, known as Hebbian learning. This rule has become a fundamental principle in
understanding how neural networks learn.

1950: Alan Turing's influential paper, "Computing Machinery and Intelligence," published in 1950,
introduced the Imitation Game, a test designed to assess a machine's ability to exhibit intelligent
behavior indistinguishable from that of a human.

1952: Arthur Samuel, a computer scientist, created a groundbreaking checkers program in 1952. This
program was the first of its kind, capable of learning and improving its checkers skills independently.

1955: John McCarthy organized a pivotal workshop at Dartmouth in 1955, where the term "artificial
intelligence" was coined and introduced to the public for the first time. This event marked a significant
moment in the history of AI research.

In 1972, AI made its debut in medicine with MYCIN.

This expert system, created by Ted Shortliffe at Stanford University, was designed to assist doctors in
diagnosing and treating diseases. MYCIN used a database of medical knowledge and rules to provide
recommendations for treatment. This marked a significant step forward in using artificial intelligence
to enhance healthcare.

2011 Onwards: Artificial intelligence (AI) and machine learning are changing the way healthcare is
delivered. These technologies were originally used in biological sciences, but they have expanded to
other medical fields, such as Medical Imaging, Disease Prediction, Molecular Modeling, Electronic
Health Records (EHRs) and also a crucial impact in pharma.

It is widely accepted that AI tools will augment rather than replace the roles of healthcare
professionals. These tools are poised to assist medical staff with various tasks, including administrative
processes, clinical documentation, patient engagement, and specialized functions like image analysis,
medical device automation, and patient monitoring. This review aims to outline the evolution of AI in
healthcare, tracing its development from the 1960s to today's cutting-edge applications in fields like
precision medicine, public health and immunization, medical education, and telemedicine.
DISCIPLINES IN WHICH ARTIFICIAL INTELLIGENCE
CONTRIBUTES SIGNIFICANTLY TO THE
ENHANCEMENT OF MEDICATION SAFETY AND THE
ACCURACY OF COMPOUNDING PROCESSES
Pharmacy practice constitutes a fundamental aspect of the healthcare system, facilitating the safe and
effective management of medications and the optimization of patient care. This is accomplished through
a variety of activities, including medication reconciliation, comprehensive medication reviews,
medication therapy management (MTM), provision of drug information, patient education, monitoring
of adverse drug reactions (ADRs), and collaboration across interprofessional teams, medication
compounding and much more.

The integration of artificial intelligence technologies empowers pharmacists with advanced tools and
systems that enhance the precision of evidence-based clinical decision-making. Utilizing AI algorithms
and machine learning techniques, pharmacists can rapidly process large datasets, including electronic
health records, laboratory findings, and medication profiles. This analytical capacity allows for the
identification of potential drug-drug interactions, the evaluation of the safety and efficacy of
pharmacotherapies, and the formulation of tailored recommendations that address the specific needs of
individual patients.

Various such fields involves:

• Drug Discovery and Drug Development: Artificial intelligence (AI) holds the promise of
transforming the drug discovery process by enhancing efficiency, accuracy, and speed.
Nevertheless, the effective implementation of AI relies on the availability of high-quality data,
the consideration of ethical issues, and an awareness of the limitations inherent in AI-driven
methodologies. It includes,
PERSONALISED MEDICINES
NANOMEDICINES
MICROFLUIDICS
DRUG FORMULATION
DRUG-EXCIPIENT COMPATIBILITY
DRUG SOLUBILITY AND AVAILABILITY

• DIAGNOSTIC TOOL: With all the

advances in medicine,
effective disease diagnosis is
still considered a challenge on
a global scale. The
development of early diagnostic tools is an ongoing challenge due to the
complexity of the various disease mechanisms and the underlying symptoms.
AI can revolutionize different aspects of health care, including diagnosis. ML
is an area of AI that uses data as an input resource in which the accuracy is
 highly dependent on the quantity as well as the quality of the input data that
can
combat some of the challenges and complexity of diagnosis. It includes,
TRACKING OF SYMPTOMS
DETERMINING PATIENT’S PHENOTYPE

MEDICAL IMAGING
DNA AND RNA SEQUENCING
LAB TESTS
Infection Risk Prediction

DNA PATIENT’S
SEQUENCE PHENOTYPE
PATIENT’S HISTORY
PATIENT’S
HISTORY

TRACKING OF
SYMPTOMS
GENE
EXPRESSION DATA SET
AI LEARNING
METHODS

LIFE
IMAGING
STYLE

RNA
PERSONALISED
SEQUENCE
LAB TESTS MEDICINES ANALYSIS AND
VISUALIZATION
RISK DATA
ASSESSMENT ANALYSIS

AI IN
PRECISION
AND
COMPOUNDING REAL TIME
MONITORING
CONSISTENCY

• IN COMPOUNDING : Although pharmacy compounding automation offers numerous

advantages, it also presents specific challenges. The initial capital expenditure associated with
the adoption of automated systems can be significant, potentially deterring smaller pharmacies
from implementation. Additionally, the integration of these systems requires extensive training
and adaptation for personnel, which may lead to temporary disruptions in workflow during the
transition period. It includes,
DATA ANALYSIS
ERROR DETECTION
PREDICTIVE MODELLING
REAL TIME MONITORING
PRECISION AND CONSISTENCY

• IN PHARMACOVIGILANCE : Pharmacovigilance plays a critical role in ensuring the safety and

efficacy of pharmaceutical products and medical devices throughout their entire lifecycle.
Traditional approaches to monitoring adverse drug reactions (ADRs) are often limited by
resource constraints and may lead to underreporting of these reactions. A noteworthy
advancement in the field of pharmacovigilance is the integration of artificial intelligence (AI)
technologies into ADR reporting systems, which enhances data analysis and reporting
capabilities. It includes,
 ADVERSE DRUG REACTION’S AND ADVERSE EVENT REPORTING

INDIVIDUAL CASE SAFETY REPORTS

EXTRACTING DRUG-DRUG INTERACTION

SIMULATIONS OF CLINICAL TRIALS

IMPROVING DRUG SAFETY

DETERMINING DRUG EFFICACY

SIGNAL DETECTION

AI IN
PHAMACOVIGILANCE

OVERALL BENEFITS OF AI IN HEALTHCARE

• AI in Revolutionizing Healthcare Diagnosis:
The healthcare sector is experiencing a significant transformation thanks to generative artificial
intelligence, particularly in how doctors and medical professionals diagnose conditions. By creating
artificial but realistic medical data and simulations, this technology is making diagnostic tools more
powerful and precise than ever before. These advances are doing more than just improving how
accurately we can spot health issues - they're reshaping how healthcare providers make clinical decisions
and deliver care to their patients.

• Making Healthcare Clearer for Patients:

Generative AI is transforming how patients learn about their health conditions by turning complex
medical information into clear, easy-to-understand visuals and simulations. When patients can actually
see and grasp what's happening in their bodies, they become more actively involved in their own
healthcare journey. This visual approach helps bridge the gap between medical expertise and patient
understanding, resulting in better teamwork between doctors and patients. When patients truly
understand their condition, they're more likely to stick to their prescribed treatments and make the
necessary lifestyle changes to improve their health.

• Helping Patients Better Understand Their Health:

Thanks to generative AI, complex medical concepts are being translated into simple, visual explanations
that patients can easily understand. By creating detailed visuals and interactive models, this technology
helps patients see exactly what's going on with their health, rather than just hearing about it. This clear
understanding leads to patients taking a more active role in managing their health - they're not just
following doctor's orders, but truly understanding why each step matters. When medical information
clicks for patients, they're naturally more motivated to follow through with their treatment plans and
adopt healthier habits. It's like turning on a light in a dark room - once patients can clearly see the path
to better health, they're more likely to walk it.

• The Emergence of Virtual Health Assistants:

The impact of AI technology on healthcare has been nothing short of incredible. The emergence of
virtual health assistants is particularly noteworthy, as they provide patients with round-the-clock access
to critical healthcare information. These chatbots and voice-enabled systems can assist with everything
from scheduling appointments to addressing basic medical queries. By streamlining healthcare delivery
and enhancing patient engagement, virtual health assistants are transforming the way healthcare is
administered. A machine-learning show can learn the designs of wellbeing directions of endless numbers
of patients. This office can offer assistance doctors to expect future occasions at master level, drawing
from data well past the person physician's hone involvement (Rajkomar, A., Dean, & Kohane, 2019). I
strongly believe that this technology holds immense potential to revolutionize healthcare delivery in
numerous ways, and I eagerly anticipate its continued evolution in the coming years.

• Tailoring Medical Care: Progress and Limitations:

While AI shows great promise in healthcare, we need to be realistic about what it can and cannot do. In
specific cases, AI-powered decision support tools have proven they can match or even outperform
human medical experts. However, it's important not to oversimplify - we can't make broad claims about
how AI will work in every medical situation. The COVID-19 pandemic provided a clear example of AI's
limitations, showing us that artificial intelligence isn't a cure-all solution for every healthcare challenge.

Just as we wouldn't expect one medicine to treat every illness, we shouldn't expect AI to solve every
medical decision-making challenge. The key is understanding where and when these tools can be most
effectively used to support, rather than replace, human medical expertise.

TECHNOLOGIES THAT ARE PROVING ARTIFICIAL

INTELLIGENCE A MASTER STROKE ON A WAY TO
DEVELOPMENT OF PHARMA SECTOR
The rise of artificial intelligence (AI) is increasingly influencing various sectors. It is anticipated that AI will
have significant effects on global productivity, equality and inclusion, environmental outcomes, and
more, both in the short and long term. While there are reported potential impacts of AI that suggest
both positive and negative consequences for sustainable development, there has yet to be a
comprehensive study that systematically evaluates how AI could affect all dimensions of sustainable
development—specifically, the 17 Sustainable Development Goals (SDGs) and their 169 associated
targets outlined in the 2030 Agenda for Sustainable Development. This represents a crucial gap in
research, as AI could play a vital role in achieving all the SDGs. The future of AI in the pharmaceutical
industry is set to bring transformative advancements across several key areas. In drug discovery and
development, AI can analyze extensive datasets to identify promising drug candidates, predict their
effectiveness, and evaluate safety profiles, thereby accelerating the creation of new medications. Some
of the major technologies in which AI had proved itself as a sustainable tool:
• ARTIFICIAL NEURAL NETWORK: Neural networks consist of interconnected neurons that
collaborate to perform mathematical computations aimed at solving complex problems. They
encompass various technologies, including deep learning and machine learning, as components
of artificial intelligence.

Artificial neural networks aim to mimic human learning processes. They are structured with an
input layer, one or more hidden layers, and an output layer. Each node in these layers is
connected to others, each having its own weight and threshold. A node becomes activated when
its input surpasses a certain threshold.

• PERSONALIZED MEDICINES BY RESHAPING PHARMACOGENOMICS: Personalized medicine is

changing the landscape of healthcare, with artificial intelligence (AI) playing a key role in this
evolution. AI technologies have significantly improved our ability to process extensive and
intricate data, leading to enhanced diagnosis and treatment outcomes. This article will delve into
the important contributions of AI in transforming personalized medicine, its influence on disease
identification and diagnosis, and the implications for the future of healthcare.
Pharmacogenomics, which explores how a person's genetic profile affects their reactions to
medications, offers a valuable opportunity for tailored medical treatments. Personalization in
drug development follows a more step-by-step approach, which includes pharmacogenomic
(PGx) assessment, selection, and testing. This process relies heavily on comprehensive clinical
data mining that focuses on genotype-driven interventions for individual patients. AI enhances
the predictive power of pharmacogenomics, enabling healthcare providers to establish a new
standard of care. With the appropriate tools, this industry-wide shift can lead to approaches that
are both highly precise and centered around the needs of patients.

• 3D BIOPRINTING: 3D bioprinting techniques allow for the accurate placement of living cells,
biomaterials, and biomolecules, representing a promising method for creating functional tissues
and organs. Recent developments in this field have enabled researchers to construct in vitro
models with intricately controlled micro-architectures, which are useful for drug testing and
disease modeling. Additionally, artificial intelligence (AI) has been integrated into various stages
of 3D bioprinting, including medical image reconstruction, selection of bioinks, and the printing
process itself, utilizing both traditional AI and machine learning methods. AI’s capacity to
manage complex datasets, perform intricate calculations, learn from previous experiences, and
dynamically optimize processes makes it an essential asset in enhancing 3D bioprinting
technologies.

• WEARABLE DEVICES: Digital wearable health devices, including smartwatches, smart rings, and
fitness trackers, have become widespread, but their functionalities are poised to grow
significantly with the integration of AI. These devices will evolve beyond merely tracking basic
health metrics like heart rate and steps to offering personalized health insights based on
individual needs.

By utilizing machine learning techniques, AI algorithms can analyze large volumes of data
collected from these wearables to identify patterns and anomalies that may signal potential
health concerns. For example, AI can detect subtle variations in a user’s vital signs and predict
the onset of conditions such as atrial fibrillation or sleep apnea. This predictive ability facilitates
early intervention, potentially preventing serious health issues.

• DIAGNOSIS: The integration of AI with traditional medical imaging techniques has accelerated
the process of diagnosing diseases. For example, AI-assisted analysis of retinal images facilitates
the early detection of diabetic retinopathy. Additionally, natural language processing (NLP)
allows for the swift analysis of textual clinical records, providing valuable insights for precise
diagnosis and patient care. In the field of radiology, AI algorithms have demonstrated their
 ability to interpret medical images, helping radiologists identify various diseases. These AI-driven
systems can spot abnormalities in X-rays, MRIs, and CT scans, leading to quicker and more
accurate diagnoses. Likewise, AI has made notable strides in pathology, transforming the field by
speeding up slide processing and improving disease detection.

A. ARTIFICIAL NEURAL C. 3D BIOPRINTING

NETWORK
ARTIFICIAL
INTELLIGENCE

B. PERSONALIZED MEDICINES
D. WEARABLE DEVICE E. DIAGNOSI
ISSUES CONFRONTING ARTIFICIAL
INTELLIGENCE IN HEALTHCARE
Artificial intelligence (AI) holds the promise to fundamentally transform healthcare by facilitating early
diagnoses, optimizing treatment efficacy, and enabling preventive interventions. Nevertheless, the
incorporation of AI into complex healthcare ecosystems presents a myriad of challenges. A thorough
examination of the barriers that must be surmounted is crucial to fully harness the potential of AI in
enhancing patient outcomes and advancing overall healthcare efficiency.

Artificial intelligence (AI) possesses the capacity to significantly enhance the personalization,
predictability, prevention, and interactivity of healthcare delivery. It is anticipated that AI will persist in
its current trajectory, ultimately evolving into a sophisticated and effective instrument within the
healthcare domain. Nonetheless, AI-driven systems engender critical concerns regarding data security
and patient privacy. Due to the sensitive nature of health records, they are frequently targeted by
cybercriminals during data breaches. The lack of standardized protocols governing the ethical application
of AI and machine learning (ML) in healthcare further complicates these challenges. The absence of
universally accepted guidelines raises ethical questions about the extent to which AI can be utilized
within healthcare environments. Consequently, ensuring the confidentiality of medical records is of
utmost importance. This study elucidates the potential drawbacks of AI implementation in the
healthcare sector and offers strategies to mitigate these issues.

• Challenges Pertaining to Ethics and Privacy: The healthcare sector faces significant ethical and
privacy challenges, necessitating rigorous compliance with relevant laws and regulations. The
adoption of AI in medicine introduces a variety of issues related to patient data protection, the
ethical implications of technological advancements, and the overall impact on both healthcare
providers and patients. To maximize the benefits of AI in healthcare, it is crucial to make
strategic decisions that balance conflicting interests and values, including privacy, accountability,
intellectual property, and transparency. Understanding the evolving landscape of privacy
concerns in healthcare is vital, as establishing trust is key. Ethical issues frequently arise in the
deployment of AI technologies within healthcare environments.
• Performance Indicators with Limited Clinical Applicability: The criteria used to assess the
success of an AI model are not always applicable to clinical environments. This gap between the
clinical effectiveness seen in practice and the technical accuracy of AI evaluations is referred to
as the AI chasm. To bridge this divide, it is essential for developers and clinicians to collaborate in
examining how AI algorithms can enhance patient care. One effective method for this is decision
curve analysis, which allows for the assessment of an AI model's accuracy by comparing datasets
and estimating its potential success in practical-world clinical applications.

• Security issues: AI products today depend on a variety of electronic devices to operate, such as
computers, smartphones, and wearable technology. There are three main security concerns
regarding this hardware that warrant attention. First, even the most advanced physically
unclonable functions can be compromised by factors like cost, temperature changes, and
electromagnetic interference. Second, the intricate nature of medical expertise combined with
information technology makes it challenging for both doctors and engineers to effectively utilize
AI that incorporates multiple technologies. Engineers need to be retrained to access and analyze
medical system data, which may disrupt clinical workflows and lead to potential data breaches.
Meanwhile, healthcare providers may struggle to understand the underlying principles and
practical applications of AI products, resulting in inefficiencies and a higher likelihood of errors.
Lastly, the security of AI networks is a critical issue; an attack or failure at crucial nodes within
the complex network could trigger a widespread cascading failure.

• Obstacles in Machine Learning Research: AI algorithms have the potential to suffer from a host
of shortcomings, including inapplicability outside of the training domain, bias and brittleness
 (tendency to be easily fooled). Important factors for consideration include dataset shift,
accidentally fitting confounders rather than true signal, propagating unintentional biases in
clinical practice, providing algorithms with interpretability, developing reliable measures of
model confidence, and the challenge of generalization to different populations.
Tackle Financial and Resource Limitations: Implementing AI in healthcare can be quite costly,
as significant investments are needed for data infrastructure and computing resources, which can
be particularly challenging for smaller organizations. To address this, sharing costs, expertise,
and resources becomes essential; exploring different partnership models, such as public-private
collaborations and consortia, can be beneficial.

Additionally, cloud computing and managed services can provide access to AI capabilities
without requiring substantial upfront expenditures on hardware and infrastructure. AI can also
present opportunities for long-term cost reductions and operational efficiencies, helping to
mitigate initial financial burdens.
 AND PRIVACY

LEARNING AND
FINANCIAL
ADAPTABILITY

ETHICS

SECURITY AI CHASM